Patents by Inventor Barbara Porton

Barbara Porton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DNA encoding the human synapsin III gene and uses thereof
    Publication number: 20030082645
    Abstract: A new synapsin protein, designated synapsin III, its amino acid sequence, and its human gene have been isolated and characterized. Furthermore, isoforms of synapsin III, e.g., synapsin IIIa, IIIb and IIIc, and have isolated and characterized, and cDNA encoding these isoforms has also been isolated and characterized. The synapsin III gene is located on human chromosome 22, in the vicinity of a region previously identified as a susceptibility locus for schizophrenia. The information and experimental tools provided by this discovery can be used to generate new therapeutic agents or diagnostic assays for this new protein, its associated mRNA or its associated genomic DNA. Due to its role in neurotransmission and synaptogenesis, isoforms of synapsin III are associated with the symptoms of psychiatric diseases, especially schizophrenia.
    Type: Application
    Filed: April 15, 2002
    Publication date: May 1, 2003
    Inventors: Paul Greengard, Barbara Porton, Hung-Teh Kao
  • DNA encoding the human synapsin III gene and uses thereof
    Patent number: 6429010
    Abstract: A new synapsin protein, designated synapsin III, its amino acid sequence, and its human gene have been isolated and characterized. Furthermore, isoforms of synapsin III, e.g., synapsin IIIa, IIIb and IIIc, and have isolated and characterized, and cDNA encoding these isoforms has also been isolated and characterized. The synapsin III gene is located on human chromosome 22, in the vicinity of a region previously identified as a susceptibility locus for schizophrenia. The information and experimental tools provided by this discovery can be used to generate new therapeutic agents or diagnostic assays for this new protein, its associated mRNA or its associated genomic DNA. Due to its role in neurotransmission and synaptogenesis, isoforms of synapsin III are associated with the symptoms of psychiatric diseases, especially schizophrenia.
    Type: Grant
    Filed: August 5, 1998
    Date of Patent: August 6, 2002
    Assignee: The Rockefeller University
    Inventors: Paul Greengard, Barbara Porton, Hung-Teh Kao
  • DNA ENCODING THE HUMAN SYNAPSIN III GENE AND USES THEREOF
    Publication number: 20020064811
    Abstract: A new synapsin protein, designated synapsin III, its amino acid sequence, and its human gene have been isolated and characterized. Furthermore, isoforms of synapsin III, e.g., synapsin IIIa, IIIb and IIIc, and have isolated and characterized, and cDNA encoding these isoforms has also been isolated and characterized. The synapsin III gene is located on human chromosome 22, in the vicinity of a region previously identified as a susceptibility locus for schizophrenia. The information and experimental tools provided by this discovery can be used to generate new therapeutic agents or diagnostic assays for this new protein, its associated mRNA or its associated genomic DNA. Due to its role in neurotransmission and synaptogenesis, isoforms of synapsin III are associated with the symptoms of psychiatric diseases, especially schizophrenia.
    Type: Application
    Filed: August 5, 1998
    Publication date: May 30, 2002
    Inventors: PAUL GREENGARD, BARBARA PORTON, HUNG-TEH KAO
  • DNA encoding the human synapsin III gene and uses thereof
    Patent number: 6040168
    Abstract: A new synapsin protein, designated synapsin III, its amino acid sequence, and its human gene have been isolated and characterized. The synapsin III gene is located on human chromosome 22, in the vicinity of a region previously identified as a susceptibility locus for schizophrenia. The information and experimental tools provided by this discovery can be used to generate new therapeutic agents or diagnostic assays for this new protein, its associated mRNA or its associated genomic DNA. Due to its role in neurotransmission and synaptogenesis, this synapsin III is associated with the symptoms of psychiatric diseases, especially schizophrenia.
    Type: Grant
    Filed: August 6, 1997
    Date of Patent: March 21, 2000
    Assignee: The Rockefeller University
    Inventors: Paul Greengard, Barbara Porton, Hung-Teh Kao